Advertisement

ADVERTISEMENT

FDA

FDA Approves Margetuximab for Metastatic Breast Cancer
FDA Alerts
FDA Approves Margetuximab for Metastatic Breast Cancer
12/17/2020
12/17/2020
Journal of Clinical Pathways
News
FDA Approves Cancer Drug to Treat Relapsing Multiple Sclerosis
08/21/2020
A drug that was first approved in 2009 for the treatment of chronic lymphocytic leukemia has now been approved by the FDA to treat relapsing forms of multiple sclerosis.
A drug that was first approved in 2009 for the treatment of chronic lymphocytic leukemia has now been approved by the FDA to treat relapsing forms of multiple sclerosis.
A drug that was first approved...
08/21/2020
Neurology
News
FDA Approves Treatment for Neuromyelitis Optica Spectrum Disorder
08/17/2020
The US Food and Drug Administration has approved a new treatment for neuromyelitis optica spectrum disorder among adults with the AQP4 antibody.
The US Food and Drug Administration has approved a new treatment for neuromyelitis optica spectrum disorder among adults with the AQP4 antibody.
The US Food and Drug...
08/17/2020
Neurology
News
FDA Approves Drug for Dravet Syndrome
06/26/2020
The FDA has approved a drug therapy to treat seizures associated with Dravet syndrome–a chronic, rare, and life-threatening form of epilepsy–among patients aged 2 years or older.
The FDA has approved a drug therapy to treat seizures associated with Dravet syndrome–a chronic, rare, and life-threatening form of epilepsy–among patients aged 2 years or older.
The FDA has approved a drug...
06/26/2020
Neurology
News
FDA Approves Neurostimulation System for Chronic Low Back Pain
06/23/2020
The FDA has approved an implantable neurostimulation system designed for the treatment of intractable chronic low back pain associated with multifidus muscle dysfunction.
The FDA has approved an implantable neurostimulation system designed for the treatment of intractable chronic low back pain associated with multifidus muscle dysfunction.
The FDA has approved an...
06/23/2020
Neurology
News
FDA Approves First Tau Pathology Drug
05/29/2020
The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
The FDA has granted a landmark...
05/29/2020
Neurology
News
FDA Approves New Acute Treatment for Migraine With or Without Aura
12/26/2019
It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.
It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.
It is the first drug in the...
12/26/2019
Neurology
News
FDA Approves New Generic for Adults With MS
12/06/2019
Three applications for the first generic capsules have been granted by the US Food and Drug Administration.
Three applications for the first generic capsules have been granted by the US Food and Drug Administration.
Three applications for the first...
12/06/2019
Neurology
News
FDA Approves New Option for Adults With Partial-Onset Seizures
11/22/2019
This approval comes after the drug was found to be safe and effective in 2 randomized, double-blind, placebo-controlled trials including 655 adults with partial-onset seizures.
This approval comes after the drug was found to be safe and effective in 2 randomized, double-blind, placebo-controlled trials including 655 adults with partial-onset seizures.
This approval comes after the...
11/22/2019
Neurology
News
FDA Approves New Treatment for IBS-C
09/13/2019
The NHE3 sodium transport inhibitor was approved for use after results from 2 clinical trials showed increased bowel movements and decreased abdominal pain among individuals with IBS-C.
The NHE3 sodium transport inhibitor was approved for use after results from 2 clinical trials showed increased bowel movements and decreased abdominal pain among individuals with IBS-C.
The NHE3 sodium transport...
09/13/2019
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use